500-Patient study aims to unlock secrets of brain bleeding disease
NCT ID NCT04204642
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting medical data and brain scans from 500 people with cerebral amyloid angiopathy (CAA), a condition that causes bleeding in the brain and memory problems in older adults. Researchers want to better understand how the disease progresses and find markers that could improve diagnosis. No new treatments are being tested; the goal is to gather knowledge that could guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve how doctors diagnose and track cerebral amyloid angiopathy, and point toward future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any therapy, and results may take years to influence patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL AMYLOID ANGIOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UOC Neurologia 5
RECRUITINGMilan, Milano, 20133, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain scan study reveals hidden differences in two common blood vessel diseases
- Your digital twin could help prevent another stroke
- Scientists hunt for biomarkers to predict brain vessel disease
- Eye injection could spot hidden brain bleeding risk
- Brain scan clues could help tell two blood vessel diseases apart
- Small study probes bleeding danger in stroke patients with 'leaky' brain vessels